Biomolecules 2012, 2(3), 389-414; doi:10.3390/biom2030389
Review

Comparative Studies of Vertebrate Platelet Glycoprotein 4 (CD36)

Eskitis Institute for Cell and Molecular Therapies, Griffith University, Nathan, QLD 4111, Australia
Received: 2 August 2012; in revised form: 6 September 2012 / Accepted: 18 September 2012 / Published: 24 September 2012
(This article belongs to the Special Issue Challenges in Glycan, Glycoprotein and Proteoglycan Research)
PDF Full-text Download PDF Full-Text [2103 KB, Updated Version, uploaded 25 September 2012 12:44 CEST]
The original version is still available [2103 KB, uploaded 24 September 2012 16:52 CEST]
Abstract: Platelet glycoprotein 4 (CD36) (or fatty acyl translocase [FAT], or scavenger receptor class B, member 3 [SCARB3]) is an essential cell surface and skeletal muscle outer mitochondrial membrane glycoprotein involved in multiple functions in the body. CD36 serves as a ligand receptor of thrombospondin, long chain fatty acids, oxidized low density lipoproteins (LDLs) and malaria-infected erythrocytes. CD36 also influences various diseases, including angiogenesis, thrombosis, atherosclerosis, malaria, diabetes, steatosis, dementia and obesity. Genetic deficiency of this protein results in significant changes in fatty acid and oxidized lipid uptake. Comparative CD36 amino acid sequences and structures and CD36 gene locations were examined using data from several vertebrate genome projects. Vertebrate CD36 sequences shared 53–100% identity as compared with 29–32% sequence identities with other CD36-like superfamily members, SCARB1 and SCARB2. At least eight vertebrate CD36 N-glycosylation sites were conserved which are required for membrane integration. Sequence alignments, key amino acid residues and predicted secondary structures were also studied. Three CD36 domains were identified including cytoplasmic, transmembrane and exoplasmic sequences. Conserved sequences included N- and C-terminal transmembrane glycines; and exoplasmic cysteine disulphide residues; TSP-1 and PE binding sites, Thr92 and His242, respectively; 17 conserved proline and 14 glycine residues, which may participate in forming CD36 ‘short loops’; and basic amino acid residues, and may contribute to fatty acid and thrombospondin binding. Vertebrate CD36 genes usually contained 12 coding exons. The human CD36 gene contained transcription factor binding sites (including PPARG and PPARA) contributing to a high gene expression level (6.6 times average). Phylogenetic analyses examined the relationships and potential evolutionary origins of the vertebrate CD36 gene with vertebrate SCARB1 and SCARB2 genes. These suggested that CD36 originated in an ancestral genome and was subsequently duplicated to form three vertebrate CD36 gene family members, SCARB1, SCARB2 and CD36.
Keywords: vertebrates; amino acid sequence; CD36; evolution; thrombospondin receptor

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Holmes, R.S. Comparative Studies of Vertebrate Platelet Glycoprotein 4 (CD36). Biomolecules 2012, 2, 389-414.

AMA Style

Holmes RS. Comparative Studies of Vertebrate Platelet Glycoprotein 4 (CD36). Biomolecules. 2012; 2(3):389-414.

Chicago/Turabian Style

Holmes, Roger S. 2012. "Comparative Studies of Vertebrate Platelet Glycoprotein 4 (CD36)." Biomolecules 2, no. 3: 389-414.

Biomolecules EISSN 2218-273X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert